Utilização da cúrcuma como tratamento da Diabetes Mellitus tipo 2: revisão de literatura
DOI:
https://doi.org/10.34117/bjdv9n4-100Keywords:
curcuma longa, Diabetes Mellitus, curcumina, curcuminóidesAbstract
Introdução: A curcumina, constituinte bioativo da Curcuma Longa L., apresenta diversas propriedades biológicas e farmacológicas, sendo documentada a sua utilização no tratamento da diabetes e suas complicações. Objetivo geral: Realizar uma revisão de literatura analisando o efeito da curcuma longa L., curcuminóides ou curcumina no tratamento e controle do diabetes mellitus tipo 2 (DM2). Método: Para a pesquisa de artigos foram utilizadas as seguintes bases de dados: Scielo e PubMed. Após a aplicação dos critérios de aceitação, 59 artigos publicados entre 2000 e 2023 apreciaram a questão problema do estudo. Resultados: Os resultados da análise evidenciaram o benefício do uso da curcuma em pó, curcuminóides e curcumina como fitoterápicos que auxiliam no tratamento de pacientes com DM2 devido aos seus efeitos antioxidantes, melhora do perfil lipídico e glicêmico, bem como parâmetros antropométricos, peso corporal e índice de massa corporal. Conclusão: Fica evidente que a curcumina possui propriedades antidiabética, antioxidante, anti-inflamatória, antibacteriana, antiviral, antifúngica e antitumoral.
References
RODACKI M,et al. Classificação do diabetes. Diretriz Oficial da Sociedade Brasileira de Diabetes, 2022.
GARCIA-GALIANO, D.; BORGES, B.C.; ALLEN, S.J.; ELIAS, C.F. PI3K signaling in leptin receptor cells: Role in growth and reproduction. J. Neuroendocrinol. 2019.
ROZANSKA, D.; REGULSKA-ILOW, B. The significance of anthocyanins in the prevention and treatment of type 2 diabetes. Adv. Clin. Exp. Med. v27,p 135–142. 2018.
ZEB et al., Alam.Análise fitoquímica e atividades biológicas do extrato etanólico do rizoma de Curcuma longa. Revista Brasileira de Biologia. 2020.
PARSAMANESH N, MOOSSAVI M, BAHRAMI A, BUTLER AE, SAHEBKAR A. Therapeutic potential of curcumin in diabetic complications. Pharmacol Res.v 136,p:181-193.2018.
SILVA, J. M., et al. Properties of Curcuma longa L. in type 2 diabetes mellitus: Integrative review. RBONE-Revista Brasileira de Obesidade, Nutrição e Emagrecimento, v14,n90,p 1180-1191.2020.
RODACKI M,et al. Classificação do diabetes. Diretriz Oficial da Sociedade Brasileira de Diabetes, 2022.
ROMERO-AROCA, P.; MENDEZ-MARIN, I.; BAGET-BERNALDIZ, M.; FERNÉNDEZ-BALLART, J.; SANTOS-BLANCO, E. Review of the relationship between renal and retinal microangiopathy in diabetes mellitus patients. Curr. Diabetes Rev. v6,p 88–101. 2010.
CERSOSIMO E, et al. Effect of Exenatide on Splanchnic and Peripheral Glucose Metabolism in Type 2 Diabetic Subjects. J Clin Endocr Metab.v 96, n6, p:1763-70,2011.
ZHOU P, XIE W, HE S, SUN Y, MENG X, SUN G, SUN X. Ginsenoside Rb1 as an Anti-Diabetic Agent and Its Underlying Mechanism Analysis. Cells. v28,n3,p:204. 2019.
ROZANSKA, D.; REGULSKA-ILOW, B. The significance of anthocyanins in the prevention and treatment of type 2 diabetes. Adv. Clin. Exp. Med. v27,p 135–142. 2018.
GARCIA-GALIANO, D.; BORGES, B.C.; ALLEN, S.J.; ELIAS, C.F. PI3K signaling in leptin receptor cells: Role in growth and reproduction. J. Neuroendocrinol. 2019.
FERRANNINI, E. et al. Early metabolic markers of the development of dysglycemia and type 2 diabetes and their physiological significance. Diabetes. v 62, 1730–1737.2013.
CHO, Nam H. et al. IDF Diabetes Atlas: Global estimates of diabetes prevalence for 2017 and projections for 2045. Diabetes research and clinical practice, v. 138, p. 271-281, 2018.
EBC Diabéticos podem chegar a 784 milhões no mundo em 2045, estima IDF. Dados são de Altlas da Federação Internacional do Diabetes. International Diabetes Federation,2023.
BRASIL. Ministério Da Saúde. Secretaria de Vigilância em Saúde. Secretaria de Gestão Estratégica e Participativa, Vigitel Brasil 2010: vigilância de fatores de risco e proteção para doenças crônicas por inquérito telefônico, Brasília, 2011.
BRASIL. Ministério Da Saúde. Secretaria de Vigilancia em Saúde. Departamento de Análise em Saúde e Vigilância de Doenças, N. Transmissíveis., Vigitel Brasil 2018: vigilância de fatores de risco e proteção para doenças crônicas por inquérito telefônico, Brasília, 2019.
PACKER,C.F; ALI S.A; MANNA, B. Diabetic Ulcer. StatPearls Publishing, 2020.
WU, J. C. et al. Chemopreventative effects of tetrahydrocurcumin on human diseases.Food Funct, v. 5, n. 1, p.12-7, 2014.
DEFRONZO, Ralph A. From the triumvirate to the ominous octet: a new paradigm for the treatment of type 2 diabetes mellitus. Diabetes, v. 58, n. 4, p. 773-795, 2009.
ZHOU P, XIE W, HE S, SUN Y, MENG X, SUN G, SUN X. Ginsenoside Rb1 as an Anti-Diabetic Agent and Its Underlying Mechanism Analysis. Cells. v28,n3,p:204. 2019.
DRIVSHOLM, T., DE FINE OLIVARIUS, N., NIELSEN, ABS et al. Sintomas, sinais e complicações em pacientes com diabetes tipo 2 recém-diagnosticados e sua relação com glicemia, pressão arterial e peso. Diabetologia. v.48, p 210–214, 2005.
KAUTZKY-WILLER, A.; HARREITER, J.; PACINI, G. Sex and Gender Differences in Risk,Pathophysiology and Complications of Type 2 Diabetes Mellitus. Endocrine Reviews. V 37,n 3, P278–316. 2016.
KOTSEVA K, et al. Cardiovascular prevention guidelines in daily practice: a comparison of EUROASPIRE I, II, and III surveys in eight European countries. Lancet.p:929-40. 2009.
MORAES, Andressa et al. Novos tratamentos para o Diabetes Mellitus tipo 2. Revista Científica da Faculdade de Medicina de Campos, v. 16, n. 2, p. 89-97, 2021.
ROZANSKA, D.; REGULSKA-ILOW, B. The significance of anthocyanins in the prevention and treatment of type 2 diabetes. Adv. Clin. Exp. Med. v27,p 135–142. 2018.
GARCIA-GALIANO, D.; BORGES, B.C.; ALLEN, S.J.; ELIAS, C.F. PI3K signaling in leptin receptor cells: Role in growth and reproduction. J. Neuroendocrinol. 2019.
MAGALHÃES, Taiza Cristina Ferraz Guerra et al. o Potencial Tecnológico e Fitoterápico da Cúrcuma. International Journal of Nutrology, v. 11, n. 01, 2018.
ZEB et al., Alam.Análise fitoquímica e atividades biológicas do extrato etanólico do rizoma de Curcuma longa. Revista Brasileira de Biologia. 2020.
MENG B, LI J, CAO H. Antioxidant and antiinflammatory activities of curcumin on diabetes mellitus and its complications. Curr Pharm Des. v19,n11,p:2101-13. 2013.
MATA, A. R. et al. Identificação de compostos voláteis da cúrcuma empregando microextração por fase sólida e cromatografia gasosa acoplada à espectrometria de massas. Ciênc.Tecnol. Aliment, v. 24, n. 1, p. 151-157, 2004.
GUL, N. et al. Studies on the Antibacterial Effect of Different Fractions of Curcuma longa Against Urinary Tract Infection Isolates. Pakistan Journal of Biological Sciences, v. 7, n.12, p. 2055-2060, 2004.
ZHOU, H. et al. Targets of curcumin. Curr Drug Targets, v. 12, n. 3, p. 332–347, 2012.
GUL, N. et al. Studies on the Antibacterial Effect of Different Fractions of Curcuma longa Against Urinary Tract Infection Isolates. Pakistan Journal of Biological Sciences, v. 7, n.12, p. 2055-2060, 2004.
KRISHNASWAMY, K. Traditional Indian spices and their health significance. Asia Pac JClin Nutr, v. 17, Suppl 1, p. 265-8, 2008.
KRISHNASWAMY, K. Traditional Indian spices and their health significance. Asia Pac JClin Nutr, v. 17, Suppl 1, p. 265-8, 2008.
SIGRIST M.S. Divergência genética em Curcuma longa L. utilizando marcadores microssatélites e agromorfológicos. Dissertação (Mestrado em Agricultura Tropical e Subtropical) - Universicade de Campinas. Campinas ,2009.
MATA, A. R. et al. Identificação de compostos voláteis da cúrcuma empregando microextração por fase sólida e cromatografia gasosa acoplada à espectrometria de massas. Ciênc.Tecnol. Aliment, v. 24, n. 1, p. 151-157, 2004.
JURENKA, J. S. Anti-inflammatory properties of curcumin, a major constituent of Curcuma longa: a review of preclinical and clinical research. Altern Med Rev, v. 14, n. 2, p. 141-53,2009.
PARSAMANESH N, MOOSSAVI M, BAHRAMI A, BUTLER AE, SAHEBKAR A. Therapeutic potential of curcumin in diabetic complications. Pharmacol Res.v 136,p:181-193.2018.
RIVERA-MANCÍA S, LOZADA-GARCÍA MC, PEDRAZA-CHAVERRI J. Experimental evidence for curcumin and its analogs for management of diabetes mellitus and its associated complications. Eur J Pharmacol. v756,p:30-7.2015.
SHEHZAD A, QURESHI M, ANWAR MN, LEE YS. Multifunctional Curcumin Mediate Multitherapeutic Effects. J Food Sci. v82, n9, p:2006-2015. 2017.
PICCININI, A. M.; MIDWOOD, K. S. DAMPening inflammation by modulating TLR signalling. Mediators of inflammation, v. 2010, 2010.
HE, Yan et al. Curcumin, inflammation, and chronic diseases: how are they linked?. Molecules, v. 20, n. 5, p. 9183-9213, 2015.
MARADANA, Muralidhara Rao; THOMAS, Ranjeny; O'SULLIVAN, Brendan J. Targeted delivery of curcumin for treating type 2 diabetes. Molecular nutrition & food research, v. 57, n. 9, p. 1550-1556, 2013.
SHEHZAD A, QURESHI M, ANWAR MN, LEE YS. Multifunctional Curcumin Mediate Multitherapeutic Effects. J Food Sci. v82, n9, p:2006-2015. 2017.
AGGARWAL, B. B.; HARIKUMAR, K. B. Potential Therapeutic Effects of Curcumin, the Anti-inflammatory Agent, Against Neurodegenerative, Cardiovascular, Pulmonary, Metabolic, Autoimmune and Neoplastic Diseases. Int J Biochem Cell Biol, v. 41, n. 1, p.40–59, 2009.
CHUENGSAMARN, Somlak et al. Curcumin extract for prevention of type 2 diabetes. Diabetes care, v. 35, n. 11, p. 2121-2127, 2012.
PIVARI, Francesca et al. Curcumin and type 2 diabetes mellitus: prevention and treatment. Nutrients, v. 11, n. 8, p. 1837, 2019.
QIN S, et al. Efficacy and safety of turmeric and curcumin in lowering blood lipid levels in patients with cardiovascular risk factors: a meta-analysis of randomized controlled trials.Nutr J. v16, n1,p:68.2017.
WATANABE BT. Avaliação do perfil bioquímico, hematológico e imunológico em pacientes com diagnóstico recente para HIV de um Centro de Referência em Santarém, Pará, Brasil. Rev Med. (São Paulo). v101, n3,e-189140. 2022.
RUZON-CAMARGO FI. Effect of dietary plants on the production of immunoglobulins A in healthy Wistar rats. Semina Ciênc Biol Saúde. v43,n1,p:119-28. 2022.
GUERRERO-ROMERO F. Hypoglycemic and an tioxidant effects of five commercial turmeric (Curcuma longa) supplements. J Food Biochem. v44, n9,e13389.2020.
MUN J. Water Extract of Curcuma longa L. Ameliorates Non-Alcoholic Fatty Liver Disease. Nutrients.v11,n10, p:2536.2019.
QIN S, et al. Efficacy and safety of turmeric and curcumin in lowering blood lipid levels in patients with cardiovascular risk factors: a meta-analysis of randomized controlled trials.Nutr J. v16, n1,p:68.2017.
VAFAEIPOUR, Zeinab; RAZAVI, Bibi Marjan; HOSSEINZADEH, Hossein. Effects of turmeric (Curcuma longa) and its constituent (curcumin) on the metabolic syndrome: An updated review. Journal of Integrative Medicine, v. 20, n. 3, p. 193-203, 2022.
AGGARWAL, B. B.; HARIKUMAR, K. B. Potential Therapeutic Effects of Curcumin, the Anti-inflammatory Agent, Against Neurodegenerative, Cardiovascular, Pulmonary, Metabolic, Autoimmune and Neoplastic Diseases. Int J Biochem Cell Biol, v. 41, n. 1, p.40–59, 2009.
SCHMATZ, Roberta et al. Effects of resveratrol on biomarkers of oxidative stress and on the activity of delta aminolevulinic acid dehydratase in liver and kidney of streptozotocin-induced diabetic rats. Biochimie, v. 94, n. 2, p. 374-383, 2012.
ARUN, N.; NALINI, N. Efficacy of turmeric on blood sugar and polyol pathway in diabetic albino rats. Plant Foods Hum Nutr, v. 57, n. 1, p. 41-52, 2002.
AGGARWAL, N. B. et al. Liposomal formulation of curcumin attenuates seizures in different experimental models of epilepsy in mice. Fundamental & Clinical Pharmacology, v. 27, n. 2, p. 169–172, 2013.
ARCARO, Carlos Alberto et al. Piperine, a natural bioenhancer, nullifies the antidiabetic and antioxidant activities of curcumin in streptozotocin-diabetic rats. PLoS One, v. 9, n. 12, p. e113993, 2014.
ANAND, P. et al. Bioavailability of curcumin: problems and promises. Mol Pharm, v. 4, p.807-18, 2007.
GUPTA, S. C. et al. Discovery of Curcumin, a Component of the Golden Spice, and Its Miraculous Biological Activities. Clin Exp Pharmacol Physiol, v. 39, n. 3, p. 283–299, 2012.
SHARMA, R. A. et al. Pharmacodynamic and pharmacokinetic study of oral curcuma extract in patients with colorectal cancer. Clin. Cancer Res, v. 7, p. 1834-1900, 2001.
IRESON, C. R. et al. Metabolism of the cancer chemopreventive agent curcumin in humanand rat intestine. Cancer Epidemiol Biomarkers Prev., v. 11, n. 1, p. 105-11, 2002.
ZENG, Y. et al. Isolation and identification of phase 1 metabolites of demethoxycurcuminin rats. Drug Metab Dispos, v. 35, n. 9, p. 1564-1573, 2007.
PRASAD, S. et al. Recent Developments in Delivery, Bioavailability, Absorption andMetabolism of Curcumin: the Golden Pigment from Golden Spice. Cancer Res Treat, v.46, n. 1, p. 2–18, 2014.
LI, J. et al. Isolation and identification of phase 1 metabolites of curcuminoids in rats.Planta Med, v. 78, p, 1351-1356, 2012.
WANG, K.; QIU, F. Curcuminoid metabolism and its contribution to the pharmacological effects. Curr Drug Metab, v. 14, n. 7, p. 791-806, 2013.
KHOPDE, S. M. et al. Inhibition of radiation-induced lipid peroxidation by tetrahydrocurcumin: possible mechanisms by pulse radiolysis. Biosci Biotechnol Biochem, v. 64, p. 503–509, 2000.
PRASAD, S. et al. Recent Developments in Delivery, Bioavailability, Absorption andMetabolism of Curcumin: the Golden Pigment from Golden Spice. Cancer Res Treat, v.46, n. 1, p. 2–18, 2014.
GUPTA, S. C. et al. Discovery of Curcumin, a Component of the Golden Spice, and Its Miraculous Biological Activities. Clin Exp Pharmacol Physiol, v. 39, n. 3, p. 283–299, 2012.
DUDHATRA, G. B. et al. A Comprehensive Review on Pharmacotherapeutics of Herbal Bioenhancers. Scientific World Journal, p. 637-953, 2012.
PARK, Eun-Kyung et al. Ginsenoside Rh1 possesses antiallergic and anti-inflammatory activities. International archives of allergy and immunology, v. 133, n. 2, p. 113-120, 2004.
